Kathryn Minor, PA
Surgical · Rockwall, TXNPI 1356427934
Payments from drug & device makers
Across 134 payments — averaging $28.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microport Orthopedics Inc$349
- Sobi, Inc$272
- AstraZeneca$244
- Astellas Pharma US Inc$194
- Novartis$192
- Pfizer$190
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,44590%
- Education$36910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microport Orthopedics Inc | 2 | $349 |
| Sobi, Inc | 6 | $272 |
| AstraZeneca(2 entities) | 7 | $244 |
| Astellas Pharma US Inc | 6 | $194 |
| Novartis | 9 | $192 |
| Pfizer | 8 | $190 |
| E.r. Squibb & Sons, L.L.C. | 9 | $186 |
| Zimmer Biomet | 1 | $182 |
| Daiichi Sankyo Inc. | 8 | $175 |
| GSK | 9 | $171 |
| Merck | 9 | $162 |
| Stemline Therapeutics Inc. | 8 | $136 |
| Lilly USA, LLC | 3 | $133 |
| Incyte Corporation | 1 | $124 |
| Johnson & Johnson | 2 | $111 |
| AbbVie | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $103 |
| Adaptive Biotechnologies Corporation | 4 | $100 |
| Vertex | 3 | $76 |
| Gilead(2 entities) | 4 | $75 |
| Array Biopharma Inc | 3 | $53 |
| Pharmaessentia USA Corporation | 2 | $47 |
| Geron Corporation | 2 | $45 |
| Eisai Inc. | 2 | $41 |
| Morphosys, US Inc. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| CTI Biopharma Corp. | 1 | $24 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $24 |
| Amgen | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Sanofi | 1 | $22 |
| Shield Therapeutics Inc | 1 | $21 |
| Bayer | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Seagen Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MPO Medial Pivot Knee$349
- JAKAFI$124
- Enhertu$124
- DOPTELET$119
How this compares
$3,814 in reported general payments places this provider in the 90th percentile of 804 surgical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $13,542 |
| Letrozole | 58 | $1,427 |
| Tamoxifen Citrate | 24 | $781 |
| Hydroxyurea | 14 | $405 |
| Anastrozole | 30 | $371 |
| Potassium Chloride | 14 | $294 |
| Ondansetron Hcl | 13 | $176 |
| Ondansetron OdtOndansetron | 12 | $122 |
| Ciprofloxacin Hcl | 14 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $190 | $13,54224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 804 surgical providers in Texas.
Other surgical in Rockwall
- Shelby WegmanRockwall$6K
- Markus BaderRockwall$5K
- Courtney DunavantAustin$389K
- Krista GranthamSan Antonio$187K
- Gerald BuchertBellaire$148K
- Gilberto SaenzGeorgetown$70K
- Andrea McNielHumble$48K
- Marilyn ShookHouston$46K
- Henry KinnebrewAustin$40K
- Josephine KarlDallas$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.